Prognosis
Kennedy 'ban' may not work.
View in browser
Bloomberg

Prognosis is exclusively for Bloomberg.com subscribers. As a loyal reader, you’re receiving a complimentary trial. If you’d like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $149 for your first year (usually $299).

Hi, it’s Anna in Virginia. When I started to hear rumblings that Robert F. Kennedy Jr. would phase out use of artificial food dyes, I thought, “Wow, he’s really going to do it.” But when the big announcement came, that’s not what happened. I’ll explain, but first ...

Today’s must-reads

  • UnitedHealth replaced its CEO after its Medicare strategy sputtered.
  • Novo Nordisk’s decision to stop making insulin pens will limit treatment options for children with diabetes, a report says.
  • GSK and iTEOS ended development of an experimental lung cancer drug.
  • Opinion: Other rich nations need to pay more for drug development.

Food dye fail

Despite what some media outlets (not Bloomberg!) reported about artificial colors being banned from US food, what officials announced on April 22 was far less impactful. They essentially asked the food industry to, pretty please, stop using synthetic colors by the end of 2026. 

The food industry hasn’t agreed to any of this.

This wasn’t the only time the Trump administration has made a big promise for broad changes only to pull back. Earlier this week, a pledge to slash prescription drug prices turned out far weaker than drugmakers’ feared.

Even if government officials and food companies eventually hammer out some kind of voluntary deal on food dyes, it’s not a real long-term solution. 

Marion Nestle, a nutrition and food studies professor emerita at New York University and the nation’s preeminent expert on nutrition politics, said she’s “baffled” by Health and Human Services Secretary Robert F. Kennedy Jr.’s assumption that the industry will play nice. Food companies need explicit regulation, she said. 
 
“They don’t want to go first,” she said. “General Mills tried this with Trix. The message was ‘Don’t do this, you’re going to lose sales.’ But if everybody had to do it, then they would.”

She spoke about the various politicians and expert panels that have called on the food industry to stop advertising sugary snacks and beverages to children.

The World Health Organization said in 2023 that self-regulation of food marketing isn’t working and told countries they need mandatory policies to protect children.

“Voluntary agreements with industry just don’t work,” Mark Bittman, the author of more than 30 recipe and food history books and a former New York Times journalist, told me. “They might say they’re going to do something, but the whole thing is all about short public memory, and no one’s going to call them on it five years from now.”

Bittman pointed me to the FDA’s effort to promote judicious antibiotic use in livestock.

Years of mostly voluntary guidelines yielded a dip in antibiotic sales in 2017, but they have risen slightly since in a way that doesn’t scream mission accomplished. Consumer and environmental advocacy groups blame the FDA for continuing to allow antibiotics to prevent disease in healthy animals and say the agency isn't adequately tracking use.

Kennedy had already told food industry executives he met with in March that he wanted them to remove artificial dyes from food before the end of his term. This is basically the same message he called an entire press conference for a month later where Food and Drug Administration Commissioner Marty Makary insisted that the FDA “is taking action” to remove dyes from the food supply. 

The FDA said May 9 that it approved or expanded the use of a few natural food colors, but it remains to be seen if Big Food will make the switch. — Anna Edney 

What we’re reading

Health coaches are sparking both hope and concern around the world, says the FT.

A quarter of US children have at least one parent with substance use disorder, NPR reports.

Vinay Prasad, an FDA appointee and critic of the pharma industry, has a lot to prove, writes Bloomberg Opinion’s Lisa Jarvis.

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? There's more where that came from. Browse all our weekly and daily emails to get even more insights from your Bloomberg.com subscription.

Want to sponsor this newsletter? Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices